GYPA and transient ischemic attack: However, the levels of erythrocyte-derived EVs (CD235a+; Figure 4E) decreased significantly over time at 5- and 30-days post-attacks in both TIA and AIS patients, suggesting a reduction in the activation of these cells over time following the initiation of therapy.